No definition available.
Multiple myeloma, excluding all cancers (controls excluding all cancers)
C3_MULT_MYELOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1661 |
4. Check minimum number of eventsNone |
1661 |
5. Include endpointsNone |
1661 |
6. Filter based on genotype QC (FinnGen only) |
1661 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Multiple myeloma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1661 | 728 | 933 |
| Unadjusted period prevalence (%) | 0.34 | 0.25 | 0.41 |
| Median age at first event (years) | 69.25 | 68.33 | 69.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 822
- Matched controls
- 8221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
153
Kela drug reimbursment
Lenalidomid
4810.9
323.0
428
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
323.0
808
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
659.3
323.0
675
57
C90.0
ICD-10 Finland
Multiple myeloma
+∞
323.0
775
*
L04AX04
ATC
lenalidomide; oral
+∞
323.0
395
*
XW000
NOMESCO Finland
Bone marrow biopsy
78.5
323.0
409
102
H02AB02
ATC
dexamethasone; systemic
414.9
323.0
560
42
L03AA02
ATC
filgrastim; parenteral
680.7
296.6
276
6
A04AA01
ATC
ondansetron; systemic, rectal
77.3
276.7
308
63
329
Kela drug reimbursment
Lenalidomide
1697.2
262.1
241
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
734.0
231.7
218
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
2458.8
195.9
182
*
AA1AA
NOMESCO Finland
Head X-ray examination
128.9
194.8
204
21
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
22.3
192.8
295
201
M04AA01
ATC
allopurinol; systemic
10.8
190.1
453
837
ZX112
NOMESCO Finland
Subcutaneous
222.4
188.9
189
11
L01AA03
ATC
melphalan; systemic
+∞
187.9
173
*
N02AA05
ATC
oxycodone; systemic
11.2
167.6
367
552
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
157.5
146
*
J05AB01
ATC
aciclovir; systemic
8.4
153.3
426
932
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.4
152.5
563
1858
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
148.5
138
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
29.6
142.9
196
86
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
39.0
142.0
181
59
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
1539.4
137.5
130
*
ZX120
NOMESCO Finland
Intravenous
11.6
122.8
249
297
M05BA02
ATC
clodronic acid; systemic
+∞
122.0
114
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
52.7
120.5
144
33
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
78.3
117.9
132
20
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
643.9
116.0
112
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
113.2
106
*
1XX32
NOMESCO Finland
NA
+∞
108.8
102
*
WW500
NOMESCO Finland
Blood transfusion
25.2
108.3
155
75
J05AB11
ATC
valaciclovir; oral
7.7
104.9
281
522
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1083.0
100.3
96
*
393
Kela drug reimbursment
Pomalidomide
+∞
100.1
94
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
16.5
97.8
163
121
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.5
95.0
181
182
NE1AA
NOMESCO Finland
Pelvis X-ray examination
8.9
92.0
214
311
WW402
NOMESCO Finland
Leucoferesis
+∞
91.4
86
*
R50.9
ICD-10 Finland
Fever, unspecified
6.6
89.6
266
554
L04AX06
ATC
pomalidomide; oral
+∞
88.1
83
*
1507
Kela drug reimbursment
Pomalidomide
+∞
88.1
83
*
B01AB05
ATC
enoxaparin; parenteral
4.7
87.3
414
1466
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
894.9
84.1
81
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
83.8
79
*
B03XA02
ATC
darbepoetin alfa; parenteral
22.9
83.1
122
62
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.4
81.9
248
522
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.8
81.2
231
447
YNB10
NOMESCO Finland
Collection of stem cells for transplant
858.2
80.8
78
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.5
80.8
134
96
L04AX02
ATC
thalidomide; oral
+∞
76.2
72
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
797.6
75.5
73
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
69.8
66
*
B03XA01
ATC
erythropoietin; parenteral
39.8
68.2
86
24
ZX108
NOMESCO Finland
Inhalation
82.1
67.3
75
10
WW409
NOMESCO Finland
Other aferesis
+∞
66.6
63
*
WW200
NOMESCO Finland
Immunization
17.5
65.9
106
69
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
64.4
61
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
62.9
217
516
398
Kela drug reimbursment
Ixazomib
+∞
62.3
59
*
JN4AD
NOMESCO Finland
Body CT examination
10.9
61.1
122
129
5BA08
NOMESCO Finland
NA
72.7
59.2
67
10
212
Kela drug reimbursment
Gout
14.6
59.0
102
79
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
58.8
493
2537
1505
Kela drug reimbursment
Ixazomib
+∞
58.0
55
*
Z51.5
ICD-10 Finland
Palliative care
12.9
56.0
102
89
L01AA01
ATC
cyclophosphamide; systemic
74.2
55.0
62
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
50.1
294
1118
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
517.6
49.9
49
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
47.8
365
1671
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
254.4
47.5
48
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
47.3
45
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.3
47.0
198
562
ZX090
NOMESCO Finland
Other technic of radiotherapy
472.5
45.7
45
*
J01MA12
ATC
levofloxacin; systemic
3.5
45.7
263
974
A02BC02
ATC
pantoprazole; systemic
3.0
45.4
611
4005
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
45.2
43
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
45.2
43
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
45.0
255
929
JN4BD
NOMESCO Finland
Extensive body CT
6.5
44.5
124
220
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.1
42
*
B01AB10
ATC
tinzaparin; parenteral
8.0
43.9
104
146
GA5AA
NOMESCO Finland
Rib X-ray examination
232.0
43.3
44
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
43.1
41
*
B74
ICPC
Malignant neoplasm blood other
226.4
42.3
43
*
TK800
NOMESCO Finland
Hemodialysis
12.4
41.8
77
68
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
81.2
41.3
46
6
NB6AA
NOMESCO Finland
Humerus X-ray examination
15.3
41.2
69
49
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
41.0
39
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.2
40.5
94
127
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
215.3
40.2
41
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
107.7
38.1
41
*
1CX01
NOMESCO Finland
NA
+∞
37.8
36
*
L01XX50
ATC
[U] ixazomib; oral
+∞
37.8
36
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
28.5
37.6
51
19
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.4
36.6
83
108
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.1
36.5
124
277
A06AD11
ATC
lactulose; oral
3.2
35.6
223
856
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
34.6
98
176
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
58.3
33.5
39
7
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
339.9
33.1
33
*
J01MA14
ATC
moxifloxacin; systemic
4.1
33.0
141
395
A04AA02
ATC
granisetron; systemic, transdermal
121.6
32.9
35
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.8
32.1
96
184
Z52.89
ICD-10 Finland
Donor of other organ or tissue
329.0
32.1
32
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
32.0
159
507
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
31.4
30
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
31.4
30
*
C03CA01
ATC
furosemide; systemic
2.4
31.1
403
2343
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
29.6
209
856
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
29.3
28
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
29.3
28
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
107.2
28.8
31
*
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
28.3
27
*
A79
ICPC
Malignancy NOS
290.8
27.9
28
*
E83.50
ICD-10 Finland
Hypercalcemia
13.8
27.2
47
36
116
Kela drug reimbursment
Prostate cancer
+∞
27.2
26
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
26.2
25
*
5BA03
NOMESCO Finland
NA
+∞
26.2
25
*
130
Kela drug reimbursment
Malignant tumour
+∞
26.2
25
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
25.1
24
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
25.1
24
*
NF3AA
NOMESCO Finland
Femur X-ray examination
10.6
25.1
49
49
M05BX04
ATC
denosumab; parenteral
5.3
24.8
78
158
N03AX16
ATC
pregabalin; oral
2.5
24.3
237
1155
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
24.1
23
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
24.1
23
*
1AA01
NOMESCO Finland
NA
246.7
23.8
24
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.6
23.7
62
100
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
23.5
330
1915
L01XG03
ATC
ixazomib; oral
+∞
23.0
22
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
23.0
22
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
22.4
388
2451
H02AB06
ATC
prednisolone; systemic
2.1
22.3
426
2803
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
16.5
22.0
35
22
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
22.0
21
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
21.9
117
389
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
21.7
69
142
E85.9
ICD-10 Finland
Amyloidosis, unspecified
44.6
21.5
26
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.0
21.5
33
19
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
20.9
20
*
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
20.9
20
*
E85.89
ICD-10 Finland
Other amyloidosis
112.8
20.7
22
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.5
20.3
48
67
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
20.1
78
197
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.8
20.1
31
18
NB4AA
NOMESCO Finland
Scapula X-ray examination
36.7
19.9
25
7
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
19.9
19
*
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
19.9
19
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
19.9
19
*
WZC30
NOMESCO Finland
Teaching
3.2
19.9
111
380
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
19.8
124
458
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.9
19.8
132
509
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
75.4
19.8
22
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
14.3
19.7
33
24
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
19.3
276
1581
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
6.4
18.9
50
82
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
18.8
18
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
71.6
18.8
21
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
102.3
18.6
20
*
127
Kela drug reimbursment
Transplant complication
13.3
18.5
32
25
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.7
18.3
53
98
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
17.8
17
*
PJA12
NOMESCO Finland
Sentinel node biopsy
183.7
17.6
18
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
43.0
17.3
21
5
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
17.2
74
206
H02AB09
ATC
hydrocortisone; systemic
8.2
17.2
38
48
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
17.0
378
2540
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
64.7
16.8
19
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.2
16.7
64
160
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
+∞
16.7
16
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
3XA02
NOMESCO Finland
NA
91.9
16.6
18
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
12.5
16.4
29
24
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.9
15.8
44
78
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
15.7
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
6BA02
NOMESCO Finland
NA
86.7
15.6
17
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
162.9
15.5
16
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.2
15.4
34
43
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.3
15.3
57
139
B02.9
ICD-10 Finland
Zoster without complication
3.5
15.3
74
227
A06AH03
ATC
naloxegol; oral
45.9
15.1
18
*
R4110
NOMESCO Finland
Physiotherapy
2.0
15.1
223
1274
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
7.4
14.9
35
49
L03AB05
ATC
interferon alfa-2b; parenteral
57.7
14.8
17
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
14.8
191
1030
JN4CD
NOMESCO Finland
Very extensive body CT
6.7
14.8
37
57
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
14.7
86
303
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
14.6
269
1668
EBA10
NOMESCO Finland
Surgical removal of tooth
3.0
14.6
88
317
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.5
14.5
51
118
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
14.4
96
369
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
22.7
14.3
20
9
N17.8
ICD-10 Finland
Other acute renal failure
7.9
14.2
32
42
L02AE02
ATC
leuprorelin; implant, parenteral
43.3
14.1
17
*
A05AA02
ATC
ursodeoxycholic acid; oral
9.3
13.8
28
31
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
15.0
13.6
22
15
NA2AD
NOMESCO Finland
Thoracic spine CT examination
15.0
13.6
22
15
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
76.4
13.6
15
*
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
13.6
13
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
34.6
13.5
17
5
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
13.3
50
124
NK6AN
NOMESCO Finland
Total body bone isotope imaging
50.8
12.9
15
*
H02AB07
ATC
prednisone; oral
2.2
12.7
144
730
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
12.7
48
120
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
SPAT1088
SPAT
Blood transfusion
20.4
12.5
18
9
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
131.9
12.5
13
*
A07AA02
ATC
nystatin; oral
2.9
12.5
77
282
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
12.3
177
990
A11CC03
ATC
alfacalcidol; systemic
4.6
12.3
42
95
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
12.2
145
751
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
12.1
41
92
N05CF01
ATC
zopiclone; oral
1.8
12.0
298
2013
A28
ICPC
Limited function/disability NOS
2.0
12.0
168
931
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.6
11.9
30
47
N05BA06
ATC
lorazepam; systemic, sublingual
3.2
11.9
64
214
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
65.9
11.6
13
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
10.2
11.5
22
22
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
11.5
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
11.5
11
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.7
11.4
49
138
HA1AA
NOMESCO Finland
X-ray mammography
5.0
11.2
35
72
N19
ICD-10 Finland
Unspecified kidney failure
3.2
11.1
58
190
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.4
11.0
32
61
WF099
NOMESCO Finland
Other radiotherapy
60.8
10.6
12
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
10.4
10
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
10.4
10
*
L03AA04
ATC
NA
+∞
10.4
10
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
10.4
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.4
10.4
49
149
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
10.4
132
699
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.4
10.4
30
57
D70.82
ICD-10 Finland
Drug-induced neutropenia
23.7
10.3
14
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.4
10.2
36
85
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
11.5
10.1
18
16
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
10.1
167
976
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.6
10.0
28
51
A40.8
ICD-10 Finland
Other streptococcal sepsis
7.1
9.8
23
33
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
9.7
199
1250
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
9.4
84
378
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
30.4
9.4
12
*
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
9.4
9
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
9.4
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
3AA13
NOMESCO Finland
NA
+∞
9.4
9
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
9.4
9
*
1XX45
NOMESCO Finland
NA
+∞
9.4
9
*
ZZR00
NOMESCO Finland
Flap of skin
12.5
9.4
16
13
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
9.4
51
173
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
10.8
9.3
17
16
WX892
NOMESCO Finland
Monitored bed care
2.5
9.3
72
302
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.3
9.3
27
52
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.2
237
1593
N18.8
ICD-10 Finland
Other chronic renal failure
3.4
9.2
43
131
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.3
9.1
44
137
L04AD01
ATC
ciclosporin; systemic
5.7
9.1
25
45
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
11.6
9.1
16
14
SPAT1255
SPAT
Intravenous administration of medicine
2.6
9.1
65
262
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
7.2
9.1
21
30
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
37.1
9.0
11
*
S42.3
ICD-10 Finland
Fracture of shaft of humerus
6.6
9.0
22
34
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.9
155
921
ECB20
NOMESCO Finland
Oral alveoplasty
9.6
8.8
17
18
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.8
657
5767
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
7.3
8.8
20
28
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
8.7
35
94
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
50.5
8.7
10
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.6
8.7
38
110
WX110
NOMESCO Finland
Local anesthesy
1.6
8.7
447
3566
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
8.7
71
307
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
11.7
8.6
15
13
L02BG04
ATC
letrozole; oral
27.8
8.5
11
*
R80
ICD-10 Finland
Isolated proteinuria
8.0
8.4
18
23
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.9
8.4
14
11
B73
ICPC
Leukaemia
+∞
8.3
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
8.3
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.3
8
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.4
8.2
38
115
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
8.2
65
274
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
8.1
29
70
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.9
8.1
19
28
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
8.0
41
134
B82
ICPC
Anaemia other/unspecified
4.1
7.9
29
72
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.9
162
1009
A02BC01
ATC
omeprazole; systemic
1.6
7.7
238
1664
HAC20
NOMESCO Finland
Total mastectomy
45.4
7.7
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.6
7.7
21
38
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
7.7
73
340
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.8
7.6
18
27
DHB00
NOMESCO Finland
Excision of lesion of external nose
25.2
7.6
10
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
25.2
7.6
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
7.5
74
351
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
80.8
7.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
80.8
7.4
8
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
80.8
7.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
80.8
7.4
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
80.8
7.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
80.8
7.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.3
160
1018
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.9
7.3
17
25
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
7.3
88
455
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
11.0
7.3
13
12
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
RS221
NOMESCO Finland
NA
6.3
7.3
18
29
B01AB04
ATC
dalteparin; parenteral
2.7
7.2
47
181
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
30.3
7.2
9
*
WVA20
NOMESCO Finland
Medicine administration
4.3
7.1
25
60
B01.9
ICD-10 Finland
Varicella without complication
20.2
7.1
10
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
7.1
53
219
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
4.2
7.0
25
61
J01CA04
ATC
amoxicillin; systemic
1.5
7.0
570
4923
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
5.0
7.0
21
43
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
7.0
61
275
A07AA09
ATC
vancomycin; oral
6.4
7.0
17
27
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
6.9
39
135
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.8
124
744
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
9.4
6.8
13
14
L57.0
ICD-10 Finland
Actinic keratosis
2.1
6.8
72
355
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
6.8
56
243
5AB01
NOMESCO Finland
NA
40.4
6.8
8
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
22.7
6.7
9
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
22.7
6.7
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.2
6.7
19
37
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.6
175
1171
ZX100
NOMESCO Finland
Oral
6.2
6.5
16
26
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.5
78
405
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
70.3
6.4
7
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
70.3
6.4
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
70.3
6.4
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
70.3
6.4
7
*
E83.51
ICD-10 Finland
Hypocalcemia
14.4
6.4
10
7
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.0
6.4
19
39
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
8.2
6.3
13
16
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
18.2
6.3
9
5
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
20399
ICD-8 Finland
Multiple myeloma
+∞
6.3
6
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
6.3
6
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
6.3
6
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
6.2
31
101
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
6.1
25
70
TK810
NOMESCO Finland
Hemofiltration
8.7
6.1
12
14
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
6.1
41
163
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
684
587
19.11
307.65
16.3
1.4
7.0
7.5
g/l
5.69
492
426
332
165
24.90
307.65
5.9
5.5
289.8
439.5
iu/ml
0.35
73
21
391
414
12.04
307.65
19.7
1.4
0.0
0.0
g/l
1.21
367
372
667
490
22.08
307.65
15.9
1.5
6.8
0.5
g/l
40.14
553
412
1018
453
56.47
307.65
19.7
1.5
244.7
47.0
mg/l
2.05
887
364
1030
1399
17.75
307.65
12.1
2.6
230.4
236.8
u/l
0.80
1011
1291
1074
1166
24.23
307.65
20.4
1.6
67.3
66.7
g/l
1.18
1052
1036
596
553
16.25
307.65
17.6
1.4
10.8
10.5
g/l
0.31
486
458
1018
452
56.60
307.65
19.7
1.5
114.2
48.4
mg/l
2.72
886
364
863
1697
9.50
307.65
4.9
2.1
1.7
1.7
%
1.53
823
1469
610
186
51.25
307.65
1.7
1.4
—
—
—
0
0
1013
438
57.72
307.65
19.0
1.5
27.1
1.8
ratio
2.15
81
37
378
406
11.76
307.65
20.3
1.5
0.0
0.0
g/l
0.00
367
371
773
636
21.86
307.65
6.1
1.4
0.8
1.2
g/l
1.52
654
572
684
587
19.11
307.65
16.3
1.4
—
—
—
0
0
849
2043
7.46
307.65
7.4
1.3
3.3
2.7
g/l
1.33
745
1140
923
794
24.91
307.65
10.9
2.1
12.4
11.0
g/l
3.16
879
718
202
12
191.50
307.65
1.2
1.7
—
—
—
0
0
684
587
19.11
307.65
16.3
1.4
4.0
3.9
g/l
0.29
422
417
419
473
11.51
307.65
18.9
1.4
37.7
37.4
g/l
0.45
385
391
748
1276
9.85
307.65
4.6
2.2
61.8
67.2
e9/l
3.51
607
981
624
544
17.77
307.65
17.3
1.5
2.9
3.1
g/l
5.14
425
421
795
1729
7.90
307.65
11.0
4.9
1.1
1.0
mmol/l
4.92
768
1578
435
433
13.26
307.65
18.7
1.5
0.2
0.0
g/l
3.00
405
390
290
253
13.68
289.24
2.7
1.4
—
—
—
0
0
294
264
13.32
287.93
2.6
1.4
—
—
—
0
0
735
1923
6.06
282.66
6.1
2.5
0.8
0.8
mmol/l
3.99
708
1757
1019
3574
5.79
277.62
9.5
2.5
3286.6
7664.4
umol/l
1.70
986
3010
229
151
17.43
267.28
4.5
3.2
1.8
1.7
%
0.10
190
111
205
123
18.87
250.53
2.6
2.7
227.2
356.1
u/ml
0.40
12
16
234
189
14.25
243.53
2.8
1.5
—
—
—
0
0
277
325
10.03
223.58
1.9
1.5
—
—
—
0
0
223
9
285.86
223.08
1.4
1.0
—
—
—
0
0
447
901
6.42
222.45
2.3
1.6
—
—
—
0
0
170
103
18.27
206.11
3.0
1.4
—
—
—
0
0
234
244
11.00
205.45
1.4
1.1
87.8
21.0
u/l
6.70
222
212
108
14
82.44
203.11
1.2
1.1
—
—
—
0
0
172
111
17.17
201.98
3.0
1.3
—
—
—
0
0
1186
5719
4.75
191.87
18.3
5.8
9.8
8.9
%
12.76
1161
5259
1183
5696
4.74
191.72
17.5
5.5
2.7
3.0
%
4.64
1156
5216
1189
5816
4.68
186.70
17.7
5.7
28.8
26.6
%
6.69
1161
5315
687
2314
4.36
180.84
3.3
1.8
—
—
—
0
0
348
665
6.36
180.69
2.4
1.6
1.4
1.5
g/l
1.25
312
565
1172
5772
4.50
179.68
16.2
5.5
54.4
58.2
%
18.22
1144
5308
157
109
15.80
177.05
4.6
3.0
59.9
56.3
%
0.67
114
72
1219
6230
4.60
176.05
17.8
5.3
1.8
1.8
e9/l
0.18
1147
5382
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
113
36
33.61
175.64
3.7
1.2
—
—
—
0
0
1230
6351
4.61
174.49
18.8
5.4
0.2
0.2
e9/l
30.96
1152
5471
120
47
27.44
174.34
2.0
2.1
31.2
44.5
%
2.38
30
19
1136
5557
4.30
173.63
14.1
3.8
33.2
35.1
g/l
21.78
1091
5076
112
36
33.29
173.60
3.6
1.2
—
—
—
0
0
112
36
33.29
173.60
3.6
1.2
—
—
—
0
0
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
1207
6243
4.41
168.33
19.5
3.8
10.3
12.2
umol/l
11.92
1192
5809
171
150
12.59
167.93
1.5
1.5
122.5
118.0
u/ml
0.08
44
25
1264
6787
4.61
166.41
42.0
6.1
3.1
4.4
e9/l
89.17
1192
5784
114
47
25.97
162.46
2.7
1.3
332.7
919.7
e6/l
3.23
43
20
628
2129
4.14
160.94
3.1
1.9
28.8
30.0
s
5.34
608
2052
1246
6753
4.38
158.49
36.1
5.4
1.2
1.2
mmol/l
0.55
1092
5679
446
1195
4.74
155.99
10.1
6.2
12.2
11.2
mmol/l
1.66
429
1122
249
412
6.93
147.91
1.7
1.2
—
—
—
0
0
145
126
12.51
142.90
4.2
2.4
—
—
—
0
0
1146
6120
3.81
142.70
28.2
5.1
1.2
1.2
mmol/l
0.59
1114
5386
85
23
38.90
137.99
2.1
1.1
—
—
—
0
0
160
170
10.31
137.48
1.7
1.2
—
—
—
0
0
535
1802
3.90
135.20
3.4
2.6
24.1
22.5
%
1.83
471
1497
139
8
189.42
134.76
4.0
1.1
—
—
—
0
0
135
7
209.71
131.77
9.7
1.1
—
—
—
0
0
551
1924
3.79
131.59
3.3
2.5
2.1
2.3
g/l
10.70
526
1762
565
2111
3.54
120.17
3.4
2.4
12.7
12.7
umol/l
0.00
542
1919
116
95
13.05
118.34
1.1
1.0
—
—
—
0
0
478
1632
3.71
116.36
2.5
1.7
—
—
—
0
0
173
253
7.52
114.47
1.3
1.3
—
—
—
0
0
856
4248
3.09
110.94
8.7
2.1
2.3
2.4
mmol/l
6.27
779
3479
468
1622
3.62
110.76
2.6
1.8
—
—
—
0
0
82
39
22.07
110.10
3.4
3.0
—
—
—
0
0
134
159
9.08
105.52
1.8
1.5
—
—
—
0
0
107
94
12.10
104.32
1.3
1.1
—
—
—
0
0
77
40
20.14
99.47
2.3
2.2
22.0
13.1
%
1.48
20
21
172
293
6.43
98.25
3.6
2.3
3.7
3.4
g/l
1.15
167
276
966
5487
2.82
91.77
10.6
3.7
—
—
—
0
0
139
204
7.34
91.32
1.7
1.3
—
—
—
0
0
110
126
9.28
88.84
1.8
1.5
—
—
—
0
0
237
587
4.54
88.60
2.5
1.7
2.3
1.7
ug/l
0.38
216
510
85
67
13.32
88.48
1.6
1.3
—
—
—
0
0
85
67
13.32
88.48
1.6
1.3
—
—
—
0
0
78
53
15.39
88.31
2.3
1.2
—
—
—
0
0
78
53
15.39
88.31
2.3
1.2
—
—
—
0
0
82
61
14.09
88.30
2.3
5.4
—
78.8
—
0
14
611
2797
2.87
87.08
6.6
2.2
—
—
—
0
0
70
40
18.23
86.47
2.2
2.3
—
—
—
0
0
86
74
12.20
84.80
2.2
1.2
—
—
—
0
0
85
72
12.39
84.64
2.2
1.2
—
—
—
0
0
72
46
16.32
84.16
3.5
1.4
644.0
417.9
e6/l
1.62
61
39
357
1241
3.39
81.78
7.5
2.4
7.1
8.4
umol/l
0.46
324
1069
116
158
7.82
81.28
1.5
1.2
230.2
250.5
u/ml
0.20
68
92
331
1119
3.45
79.07
4.4
3.6
95.8
94.8
ng/l
0.06
297
937
68
44
16.07
78.92
3.7
1.4
0.3
0.2
e9/l
0.54
60
39
122
183
7.12
78.41
1.7
1.3
—
—
—
0
0
110
160
7.29
72.65
1.7
1.3
—
—
—
0
0
66
48
14.28
71.86
3.0
1.5
—
—
—
0
0
108
160
7.15
70.12
5.5
6.5
10.5
12.6
mg/l
3.89
98
148
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
183
445
4.50
69.49
3.2
3.0
0.3
0.3
u/ml
0.50
109
275
1167
7916
2.59
68.14
14.7
4.4
6.6
6.9
mmol/l
5.28
1136
7403
854
5066
2.41
66.62
4.0
2.8
319.3
140.9
ug/l
14.67
805
4581
664
3524
2.47
66.42
2.3
2.3
3.0
3.0
mg/l
0.01
570
2969
107
168
6.74
65.77
1.6
1.3
—
—
—
0
0
238
739
3.59
64.14
2.8
1.4
5.6
3.6
ug/l
0.88
190
555
98
146
7.07
63.24
2.5
1.2
—
—
—
0
0
41
13
32.31
63.14
1.9
3.4
—
—
—
0
0
98
147
7.02
62.84
2.5
1.2
—
—
—
0
0
74
79
9.76
62.82
1.5
1.5
—
—
—
0
0
98
148
6.97
62.45
2.5
1.2
—
—
—
0
0
99
153
6.82
61.73
2.5
1.2
—
—
—
0
0
77
89
9.02
61.56
1.2
1.1
—
—
—
0
0
98
153
6.74
60.51
2.6
1.2
—
—
—
0
0
199
571
3.82
60.14
4.6
1.7
—
—
—
0
0
97
151
6.76
60.06
2.6
1.2
—
—
—
0
0
130
269
5.16
59.83
2.3
1.3
—
—
—
0
0
44
20
22.57
59.81
4.2
1.1
—
—
—
0
0
62
57
11.26
58.40
1.2
1.4
—
—
—
0
0
648
3619
2.30
55.44
4.3
3.1
0.5
0.5
e6/l
0.18
548
2739
108
209
5.46
53.51
8.4
3.4
48.9
58.1
%
6.45
108
209
242
846
3.18
53.50
1.7
1.5
—
—
—
0
0
248
896
3.08
51.74
2.4
1.7
—
—
—
0
0
104
203
5.40
51.02
6.9
3.3
2.9
4.3
e9/l
9.81
104
203
246
896
3.05
50.54
5.4
3.4
0.9
2.0
mmol/l
4.15
179
638
775
4797
2.15
49.99
4.9
3.1
1942.9
1675.7
ng/l
0.90
711
4146
505
2645
2.31
49.23
2.5
1.6
1.6
1.3
mg/l
0.64
417
2064
1284
9732
2.41
49.05
30.7
5.4
78.6
77.6
u/l
0.32
1266
8935
252
946
2.96
48.99
5.5
3.5
4.8
5.2
kpa
8.88
232
860
317
1370
2.62
46.93
7.0
3.2
1.5
2.1
mmol/l
1.63
251
1093
316
1378
2.60
45.85
7.0
3.2
5.7
5.8
kpa
1.52
311
1330
517
2816
2.21
45.20
3.3
2.5
5.7
5.1
e6/l
0.54
479
2440
121
300
4.27
44.44
3.8
3.3
1.8
1.6
mg/l
1.22
110
263
264
1092
2.69
42.40
2.2
1.8
386.4
363.2
nmol/l
0.94
252
971
261
1074
2.70
42.34
20.4
3.0
1.2
1.2
mmol/l
2.28
255
905
164
534
3.30
40.40
3.0
1.6
—
—
—
0
0
63
96
6.78
39.71
1.9
1.5
—
—
—
0
0
459
2506
2.15
38.99
5.7
2.3
2.5
2.5
mmol/l
4.78
415
2144
166
568
3.14
37.60
6.4
3.8
24.1
24.9
mmol/l
2.72
154
516
387
2053
2.15
34.90
3.8
2.9
2.3
2.3
e6/l
0.04
232
1124
587
3638
1.95
34.33
2.0
1.6
19.1
20.3
nmol/l
1.14
549
2999
407
2221
2.10
33.99
3.6
2.7
1.1
1.4
e6/l
0.64
253
1282
177
666
2.86
33.78
7.8
3.6
23.8
24.3
mmol/l
0.96
164
588
40
44
9.29
33.09
1.2
1.1
—
—
—
0
0
106
307
3.62
31.23
1.5
1.3
—
—
—
0
0
106
307
3.62
31.23
1.5
1.3
—
—
—
0
0
1109
8584
1.88
31.01
6.2
4.7
478.8
2599.3
e6/l
1.48
18
146
509
3103
1.92
30.59
2.0
1.8
1141.0
1155.1
nmol/l
0.12
416
2311
248
1176
2.30
29.04
6.6
5.9
1.2
1.5
mmol/l
3.31
241
1129
107
332
3.38
28.34
1.9
1.5
1.1
1.2
g/l
0.77
100
314
96
278
3.60
28.28
2.4
1.9
636.2
109.9
u/ml
0.57
79
222
103
324
3.32
26.69
1.8
1.5
0.2
0.2
g/l
0.27
93
310
305
1627
2.07
26.39
7.0
6.3
4.9
5.1
kpa
2.63
286
1544
304
1627
2.06
26.04
7.0
6.2
11.7
11.4
kpa
0.56
285
1543
304
1629
2.06
25.95
7.0
6.2
0.7
1.3
mmol/l
1.17
228
1233
46
79
5.96
25.79
1.7
1.4
—
—
—
0
0
123
443
2.92
25.31
2.7
3.0
—
—
—
0
0
554
3638
1.78
25.30
6.1
2.6
35.8
37.6
u/l
0.21
533
3431
33
42
8.00
24.32
1.1
1.2
—
—
—
0
0
744
5358
1.70
24.15
2.7
2.2
81.4
79.0
nmol/l
1.37
691
4624
592
4016
1.74
23.83
2.9
2.3
57.0
59.8
u/l
0.70
561
3656
63
154
4.21
23.53
1.2
1.2
215.4
224.9
miu/ml
0.06
21
53
255
1332
2.08
23.13
7.9
6.7
106.5
121.5
g/l
25.39
246
1284
772
5665
1.68
22.98
5.6
4.1
40.2
74.9
ng/l
1.75
672
4299
1119
12992
0.57
22.92
4.6
5.5
2.5
2.6
mmol/l
2.34
1024
11752
40
68
6.00
22.66
1.8
1.4
—
—
—
0
0
826
6189
1.67
22.54
2.5
2.1
91.0
93.6
pmol/l
0.89
571
3108
29
9
32.76
22.44
1.4
1.0
—
—
—
0
0
39
67
5.94
21.86
1.8
1.4
—
—
—
0
0
29
36
8.18
21.80
1.1
1.1
—
—
—
0
0
1171
9673
1.71
21.42
8.4
4.2
33.2
13.0
mm/h
77.52
1122
8856
69
193
3.69
21.40
1.1
1.2
—
—
—
0
0
52
118
4.52
21.36
1.2
1.2
—
—
—
0
0
221
1154
2.06
19.92
5.7
2.7
4.7
4.5
kpa
0.47
216
1109
33
53
6.33
19.77
2.1
1.9
2295.3
1160.8
u/ml
0.43
33
53
26
32
8.24
19.66
1.2
1.1
1006.4
1602.5
miu/ml
1.23
26
32
807
6148
1.61
19.58
3.3
2.3
—
—
—
0
0
120
493
2.55
19.10
1.4
1.8
35.3
38.2
u/l
0.68
111
411
16
10
16.15
18.52
1.8
1.5
—
—
—
0
0
1102
12654
0.62
17.99
4.3
4.9
4.3
4.5
mmol/l
3.60
1015
11495
85
306
2.87
17.50
3.1
2.4
14.7
16.3
%
3.00
47
167
1091
12529
0.62
17.35
4.2
4.8
1.3
1.4
mmol/l
11.43
997
11299
1116
12742
0.62
17.16
5.5
5.1
6.1
6.1
mmol/l
0.08
1007
11385
431
2885
1.67
17.16
5.9
4.1
140.8
439.4
ng/l
4.53
378
2460
26
38
6.94
17.00
1.5
1.2
—
—
—
0
0
17
14
12.26
16.93
2.6
1.1
31.1
18.6
u/ml
0.52
17
14
91
347
2.72
16.82
3.2
3.0
8.6
7.9
kpa
3.74
83
317
19
19
10.10
16.72
1.4
1.2
—
—
—
0
0
1070
12289
0.64
16.19
6.2
6.7
40.8
41.0
mmol/mol
0.32
986
11213
144
699
2.16
15.63
7.6
8.1
23.7
24.3
mmol/l
1.16
130
632
55
170
3.31
14.71
1.4
1.5
29.9
27.5
g/l
0.51
49
150
173
926
1.97
14.40
5.8
2.8
108.9
129.9
g/l
24.68
167
898
68
243
2.88
14.22
1.2
1.5
—
—
—
0
0
181
993
1.92
14.01
2.4
2.0
0.2
0.2
g/l
0.15
170
886
94
402
2.42
13.75
3.4
3.2
23.8
25.1
mmol/l
2.09
81
349
229
1378
1.77
13.15
5.3
3.3
—
—
—
0
0
28
57
4.98
13.12
1.2
1.1
—
—
—
0
0
14
13
10.85
12.86
1.1
1.0
—
—
—
0
0
180
1019
1.86
12.63
2.7
2.2
47.1
38.4
u/l
0.39
150
837
55
187
3.01
12.59
1.3
1.2
—
—
—
0
0
123
622
2.06
11.99
7.6
4.3
1.6
1.7
%
0.50
116
591
783
6344
1.44
11.91
4.3
3.8
0.0
0.0
estimate
0.00
175
1100
17
23
7.46
11.85
1.6
1.3
—
—
—
0
0
31
75
4.19
11.81
1.4
1.2
11.3
11.1
u/l
0.03
26
68
29
67
4.39
11.71
1.0
1.0
—
—
—
0
0
47
153
3.13
11.60
1.4
1.5
911.9
1663.8
e6/l
1.55
34
109
17
9
19.07
11.59
1.4
1.1
—
—
—
0
0
237
3570
0.61
11.23
1.6
1.6
1.7
1.3
mmol/l
2.00
218
2947
788
6442
1.42
11.14
4.4
3.9
0.0
0.0
estimate
0.80
167
1074
779
6358
1.42
11.10
5.9
5.1
0.0
0.0
estimate
0.00
172
1097
1082
12128
0.69
11.01
4.3
4.3
1.4
1.3
mmol/l
2.25
990
10835
36
103
3.55
10.89
1.3
1.1
57.1
53.3
u/l
0.22
31
73
26
59
4.46
10.74
1.2
1.3
—
—
—
0
0
131
708
1.92
10.58
3.1
2.6
0.3
0.3
e6/l
0.07
131
694
77
341
2.32
10.46
3.0
2.1
115.9
131.5
g/l
5.94
58
258
44
148
3.03
10.31
1.5
1.3
—
—
—
0
0
67
281
2.44
10.28
2.0
2.6
28.2
35.3
umol/l
2.06
49
238
106
544
2.01
9.94
2.8
2.2
592.9
932.0
ug/l
0.34
100
509
124
674
1.91
9.85
4.7
2.3
0.7
0.7
%
0.12
118
643
15
22
6.87
9.74
1.0
1.1
—
—
—
0
0
45
161
2.85
9.48
1.4
1.3
—
—
—
0
0
61
255
2.45
9.45
1.5
1.6
—
—
—
0
0
14
8
17.63
9.40
1.5
1.1
—
—
—
0
0
13
17
7.70
9.28
11.7
11.9
4.9
5.7
mmol/l
0.54
13
17
157
963
1.70
8.35
7.8
6.3
24.0
24.5
mmol/l
0.82
146
895
23
58
4.01
8.34
1.4
1.1
47.1
18.4
u/l
1.57
23
50
8
0
+∞
8.34
1.4
0.0
—
—
—
0
0
75
363
2.12
8.27
1.8
1.7
—
—
—
0
0
39
140
2.83
8.20
1.4
1.6
77195.2
74930.0
e6/l
0.01
21
82
70
340
2.11
7.67
1.4
1.5
221.3
292.1
ug/g
2.15
42
199
39
149
2.66
7.32
2.8
4.0
—
—
—
0
0
23
64
3.63
7.31
1.4
1.1
143.8
82.3
u/l
1.13
23
55
103
582
1.82
7.30
4.0
3.0
4.4
4.4
pmol/l
0.07
97
496
215
1477
1.52
7.15
3.9
3.0
293.1
240.3
ng/l
0.77
195
1368
70
362
1.97
6.51
1.2
1.1
—
—
—
0
0
68
351
1.98
6.37
1.4
1.6
0.2
0.1
iu/ml
0.25
16
77
69
359
1.96
6.32
1.2
1.1
—
—
—
0
0
6
0
+∞
6.25
1.3
0.0
—
—
—
0
0
162
1083
1.55
6.09
5.4
2.4
51.8
61.9
ml/min/173m2
3.27
98
454
18
48
3.78
6.09
1.7
1.4
—
—
—
0
0
21
64
3.31
5.87
1.3
1.0
—
—
—
0
0
9
7
12.92
5.58
1.2
1.3
—
—
—
0
0
178
1245
1.48
5.42
2.2
2.2
168.7
165.7
ug/g
0.02
147
966
8
5
16.07
5.41
1.8
3.6
—
—
—
0
0
13
30
4.36
5.30
1.4
1.3
—
—
—
0
0
8
6
13.39
5.08
1.1
1.2
295.9
233.8
nmol/l
—
8
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
56
3.24
4.90
1.1
1.1
—
—
—
0
0
111
719
1.58
4.83
2.4
2.2
11.6
14.7
nmol/l
3.25
95
617
19
62
3.09
4.79
2.0
1.5
4.3
8.1
u/l
0.47
13
28
33
144
2.32
4.79
1.1
1.1
—
18.4
—
0
6
17
54
3.17
4.49
1.0
1.1
—
—
—
0
0
7
6
11.71
4.27
1.4
1.2
—
—
—
0
0
179
1317
1.40
4.18
1.4
1.4
—
—
—
0
0
37
182
2.06
4.06
5.8
41.8
7.2
7.6
mmol/l
0.21
28
150
529
4545
1.24
3.95
2.4
2.2
163.7
242.0
u/l
1.79
501
4232
77
483
1.62
3.88
1.2
1.2
—
—
—
0
0
29
132
2.22
3.87
1.1
1.2
3.3
8.5
u/ml
—
10
66
57
331
1.75
3.82
7.3
2.8
7.3
7.7
mmol/l
0.54
57
321
7
8
8.78
3.77
1.0
1.0
—
—
—
0
0
1334
13935
0.78
3.70
76.5
21.1
118.0
135.0
g/l
209.06
1315
13625
1329
12608
1.27
3.70
58.3
14.4
21.3
25.0
mg/l
5.01
1268
9981
1334
13934
0.78
3.69
76.1
21.0
6.4
6.8
e9/l
2.11
1307
13377
1334
13933
0.78
3.68
76.1
21.0
3.8
4.5
e12/l
211.94
1306
13373
1334
13930
0.78
3.65
76.2
21.0
197.0
241.3
e9/l
76.88
1308
13442
47
264
1.80
3.54
1.2
1.1
—
—
—
0
0
7
10
7.02
3.36
1.0
1.2
—
—
—
0
0
267
2183
1.27
3.02
25.1
30.0
1.3
1.4
inr
0.52
33
299
410
3515
1.22
3.02
4.9
4.2
0.0
0.0
estimate
0.50
141
1057
1112
11765
0.83
2.98
4.9
4.7
2.1
2.1
mu/l
0.06
1037
10505
7
13
5.40
2.87
1.0
1.4
—
—
—
0
0
27
136
2.00
2.86
1.1
1.1
—
—
—
0
0
19
84
2.28
2.77
1.3
1.5
16.8
13.5
umol/l
0.73
19
74
10
31
3.24
2.77
1.2
1.1
—
—
—
0
0
27
139
1.96
2.71
1.1
1.2
1.6
2.3
u/ml
—
9
42
20
403
0.49
2.67
1.6
1.6
—
—
—
0
0
24
452
0.52
2.62
1.7
1.6
—
—
—
0
0
5
7
7.16
2.55
1.2
1.0
—
—
—
0
0
548
4894
1.18
2.53
4.9
4.1
—
—
—
0
0
10
33
3.04
2.53
1.2
1.1
—
—
—
0
0
10
33
3.04
2.53
1.2
1.1
—
—
—
0
0
42
255
1.66
2.50
1.3
1.3
—
—
—
0
0
10
34
2.95
2.41
1.2
1.1
—
—
—
0
0
41
650
0.62
2.39
1.7
1.8
—
—
—
0
0
19
90
2.12
2.39
1.0
1.2
—
—
—
0
0
8
22
3.65
2.36
1.3
1.1
—
—
—
0
0
10
35
2.87
2.30
1.2
1.1
—
—
—
0
0
5
9
5.57
2.21
1.0
1.2
—
—
—
0
0
13
54
2.42
2.20
1.0
1.1
—
—
—
0
0
8
24
3.34
2.18
1.0
1.1
—
—
—
0
0
15
68
2.22
2.11
3.8
4.2
—
—
—
0
0
5
10
5.01
2.07
1.0
1.3
—
—
—
0
0
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
65
461
1.43
1.99
4.2
3.9
3.9
3.9
mmol/l
0.03
60
422
60
423
1.43
1.91
1.2
1.2
0.3
0.2
u/ml
—
5
37
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
1058
10062
1.14
1.85
64.4
17.3
15.1
13.8
%
97.43
1045
9769
794
7415
1.14
1.84
3.9
3.0
63.4
50.5
u/l
3.13
753
6701
14
66
2.13
1.82
1.8
1.3
—
—
—
0
0
6
150
0.40
1.77
3.0
1.8
—
—
—
0
0
29
177
1.65
1.76
1.9
1.3
11.9
9.2
u/l
0.44
22
144
177
1473
1.23
1.76
2.9
2.5
5.3
7.6
ug/l
1.21
153
1271
52
365
1.44
1.72
1.8
1.6
20119.2
14135.0
e6/l
0.62
38
273
5
13
3.85
1.71
1.2
1.5
—
—
—
0
0
277
2411
1.18
1.71
1.3
1.2
1.0
1.8
u/ml
1.48
34
642
1309
13480
0.86
1.66
38.1
9.5
26.2
25.2
u/l
1.02
1291
12802
8
31
2.59
1.66
1.9
2.5
1.2
1.2
mmol/l
—
8
31
13
62
2.11
1.65
1.7
1.7
237.7
5108.1
u/l
—
7
19
97
1227
0.78
1.63
1.3
1.3
—
—
—
0
0
39
263
1.49
1.59
1.5
1.3
10.3
39.8
e6/l
0.71
31
212
39
263
1.49
1.59
1.6
1.3
22.0
658.7
e6/l
0.95
30
223
20
115
1.75
1.52
1.4
1.3
—
—
—
0
0
53
384
1.39
1.50
2.6
3.2
0.8
0.8
nmol/l
0.17
36
287
45
319
1.42
1.45
1.7
1.7
—
—
—
0
0
452
4920
0.89
1.37
4.2
4.0
21.9
8.0
mg/mmol
4.36
341
3110
5
17
2.95
1.36
1.4
1.0
—
—
—
0
0
435
4735
0.89
1.31
3.4
3.2
6.9
7.3
mmol/l
0.92
379
3934
13
69
1.89
1.28
1.7
2.0
19.6
17.9
nmol/l
0.19
13
60
5
18
2.78
1.28
1.4
1.0
—
—
—
0
0
54
407
1.34
1.24
1.4
1.4
—
—
—
0
0
9
45
2.01
1.23
1.3
1.0
—
—
—
0
0
9
45
2.01
1.23
1.2
1.6
41.2
197.3
ug/l
—
9
39
12
63
1.91
1.23
1.1
1.3
—
—
—
0
0
14
79
1.78
1.17
2.4
2.6
—
—
—
0
0
21
134
1.57
1.14
1.5
1.3
18347.1
144769.9
e6/l
1.25
13
96
22
144
1.53
1.09
1.1
1.1
—
—
—
0
0
27
186
1.46
1.06
1.4
1.5
69.6
66.2
%
0.19
19
122
10
52
1.93
1.06
1.2
1.3
—
—
—
0
0
7
33
2.13
1.05
1.1
3.3
—
—
—
0
0
51
398
1.29
0.97
1.6
1.8
—
—
—
0
0
9
50
1.80
0.96
1.0
1.1
—
—
—
0
0
495
4651
1.09
0.90
8.0
3.3
8243.9
193.9
mg/l
21.03
393
2938
1327
13528
0.91
0.89
59.4
17.7
4.0
4.0
mmol/l
1.69
1310
13100
12
71
1.70
0.89
1.5
1.1
—
—
—
0
0
12
71
1.70
0.89
1.5
1.1
—
—
—
0
0
19
127
1.50
0.88
1.9
2.1
0.5
2.0
u/field
—
8
46
280
3052
0.90
0.87
2.9
2.7
1.0
0.7
ug/l
1.61
206
2125
20
136
1.48
0.86
1.1
1.1
—
—
—
0
0
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
10
57
1.76
0.83
1.3
1.1
1.0
1.1
u/l
—
5
31
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
1326
13497
0.91
0.78
54.7
17.5
138.9
139.7
mmol/l
28.33
1309
13090
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
12
186
0.64
0.77
1.8
1.5
—
—
—
0
0
78
663
1.19
0.73
1.4
1.2
78.9
218.5
u/ml
4.62
71
605
1168
11937
0.93
0.72
45.7
13.4
68.0
73.7
ml/min/173m2
12.50
1055
9574
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.93
0.70
1.0
1.0
99.2
97.7
%
—
5
21
1118
10921
1.07
0.68
49.8
16.0
34.6
39.0
%
28.51
675
6798
24
180
1.34
0.65
1.6
1.4
—
—
—
0
0
11
73
1.51
0.56
2.5
2.3
—
—
—
0
0
422
4431
0.94
0.56
4.0
3.9
21.9
24.1
%
2.24
218
2226
19
249
0.76
0.53
1.4
1.3
—
—
—
0
0
180
1932
0.92
0.45
13.5
7.2
—
—
—
0
0
23
184
1.25
0.43
1.3
2.5
27.2
22.6
mg/l
—
5
38
5
33
1.52
0.41
1.2
1.1
151.8
204.8
pmol/l
—
5
19
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
38
324
1.18
0.40
3.8
3.5
24.8
26.6
mg/l
0.18
25
210
12
89
1.35
0.38
1.1
1.1
—
—
—
0
0
100
1090
0.91
0.37
1.7
1.7
1.4
1.6
%
1.92
84
907
5
77
0.65
0.35
1.0
1.0
—
—
—
0
0
562
5462
1.04
0.35
4.7
4.0
3.1
2.1
ug/l
1.60
497
4847
14
178
0.78
0.34
1.3
1.2
0.7
0.7
nmol/l
0.14
14
168
29
246
1.18
0.34
1.4
1.8
2.3
4.0
iu/l
1.89
11
85
35
305
1.15
0.31
1.4
1.5
—
—
—
0
0
19
157
1.21
0.29
1.3
1.4
375.8
297.0
pmol/l
0.39
14
114
13
161
0.81
0.27
1.2
1.0
—
—
—
0
0
311
3009
1.04
0.25
4.7
4.2
1.0
1.0
kg/l
0.46
54
460
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
26.0
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
22.6
—
0
5
0
11
0.00
0.21
0.0
1.0
—
1.2
—
0
6
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
186
1932
0.96
0.20
1.2
1.2
4.4
13.6
u/ml
1.93
42
705
6
51
1.18
0.19
2.2
2.6
—
—
—
0
0
6
51
1.18
0.19
2.2
2.6
—
—
—
0
0
38
413
0.92
0.17
2.4
2.3
78.7
88.4
ug/min
0.12
29
252
334
3279
1.02
0.13
1.7
1.7
427.5
30305739.6
pmol/l
2.82
278
2653
180
1845
0.97
0.11
3.9
5.0
32.5
33.4
%
0.46
133
1183
35
329
1.07
0.10
1.4
1.2
71.6
40.4
u/ml
—
6
19
204
2000
1.02
0.09
1.3
1.3
26.8
40.4
iu/ml
0.65
56
628
49
511
0.96
0.08
1.0
1.1
—
—
—
0
0
64
618
1.04
0.08
1.1
1.2
91.5
121.9
iu/ml
0.30
22
246
33
315
1.05
0.06
1.4
1.2
1.4
5.1
u/ml
—
6
53
964
9607
1.01
0.05
4.1
3.8
14.9
15.1
pmol/l
0.67
902
8532
13
125
1.04
0.00
1.2
1.1
—
62.7
—
0
15
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MULT_MYELOMA_EXALLC – Multiple myeloma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).